Skip to Main Content

Paper Details

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
JAMA Ophthalmol
76
2016
Aflibercept, Bevacizumab, DME, Diabetic Macular Edema, Diabetic Retinopathy, Ranibizumab, VEGF, aflibercept, anti-vascular endothelial growth factor, bevacizumab, diabetic macular edema, patients, ranibizumab, visual acuity impairment
Author NameAffiliation
Neil M BresslerWilmer Eye Institute, The Johns Hopkins University School of Medicine
Kenneth Bailey FreundNew York University School of Medicine
Kenneth Bailey FreundNew York University School of Medicine
Adam R GlassmanJaeb Center for Health Research
Judy E KimMedical College of Wisconsin
Philip J RosenfeldBascom Palmer Eye Institute, University of Miami Miller School of Medicine
  • 1 - 6

Datasets

Release 1.2